glp-1 type 2 diabetes receptor agonists are increasingly used to treat and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Clinical Focus on GLP-1 Agonists

doi: 10.3389/fnut.2026.1794882 Received 23 January 2026 Revised 02 March 2026 Accepted 02 March 2026 Published 24 March 2026 Volume 13 - 2026 Edited by Amin Gasmi, Francophone Society of Nutritherapy and Applied Nutrigenetics, France Reviewed by Meryem Saban Gler, Batman University, Trkiye Updates Copyright 2026 Cengiz Kaynakc

These tumor cells can not consume isocitrate to produce -KG but convert -KG to 2-hydroxyglutaric acid (2-HG)

Vangaveti, V

Martin and colleagues recommend cautious interpretation of FISH analysis given findings of similar cytogenetic alterations in Spitz tumors and melanoma [53]

Larger sizes typically offer better per-serving value

This is considerably higher than in the general heterosexual population of Australia (around 0.04%) but lower than among people injecting other drugs (2%) or gay men (8 to 12%)